Insights on Newer Treatment for Neurological Diseases

Activities of specialized brain cells are found to differ based on their location. This may help formulate better treatments for various neurological diseases.

Newer treatments for neurological diseases may soon become feasible through brain cell insights as per a study at Rutgers University, published in the journal Cell Reports.

The scientists locate immature cells in the central nervous system that could shed light on the causes of neurodegenerative diseases like multiple sclerosis—and autoimmune disease that affects the brain and nervous system—and allow for the development of better treatments.

Removing Brain Cells Reduce Symptoms of Opioid Withdrawal
Removing chemical messengers in the brain that are involved in wakefulness and addiction may make withdrawal from opioids easier and help prevent relapse.

‘Activities of specialized brain cells are found to differ based on their location. This may help formulate better treatments for various neurological diseases. ’

The researchers looked at cells known as oligodendrocytes in the brain and spinal cord that produce myelin, which protects nerve cells and allows them to work properly.

The scientists discovered that oligodendrocyte cells in the brain are distinct from oligodendrocytes in the spinal cord in a fundamental way—their metabolic processes, the essential chemical reactions that power them, are completely different.

“The cells look identical under a microscope, so everyone assumed they were the same,” said Teresa Wood, a Distinguished Professor and the Rena Warshow Endowed Chair in Multiple Sclerosis, who led the Rutgers team. “We drilled down to see what the cells are doing from a biochemical and molecular biological perspective. And we found they are definitely different.”

Human Brain Cells Not Infected by COVID Virus, Says Study
SARS-CoV-2, the virus that causes COVID-19 does not infect human brain cells. The finding raises hopes that COVID-related damage to sense of smell may be more superficial than previously feared.

This could help researchers find ways to boost, protect or restore myelin production depending on the types of cells they are targeting, said Wood, who teaches and performs research in the Department of Pharmacology, Physiology, and Neuroscience at Rutgers New Jersey Medical School.

Brain imaging in people with multiple sclerosis often shows lesions—abnormalities in the myelin coating—in the brain or spinal cord. In these cases, the myelin in those areas has disappeared and the oligodendrocytes there also have died off. A loss of myelin leads to impairments in everything from vision to muscle control. Myelin loss is also seen in brain images of patients with Alzheimer’s disease, autism, and schizophrenia, but the causation is not well understood, Wood said.

Anxiety and Dementia may be Reversible by Understanding Brain Cells� Talk
Mental health conditions like anxiety and memory ailments such as dementia may be reversible by understanding how our brain cells talk.

One hope for treatment lies in locating immature cells laced throughout the central nervous system that will mature into oligodendrocytes to make myelin and repair the lesions. Research into the characteristics of oligodendrocytes, Wood said, is central to this endeavor.

“Understanding the mechanisms regulating the production of myelin will allow us to develop better treatments for neurodegenerative diseases and for repair following injury,” said Wood, who is also a member of the Cancer Metabolism and Growth Program at Rutgers Cancer Institute of New Jersey.

Enzyme Mutation Results in Loss of Brain Cells Connection for Movement
Connection between brain cells that help control body movement is found to be weakened by a mutated enzyme.

Overall, the research team made three key findings:

Cholesterol, a building block of myelin, is produced by oligodendrocytes in the spinal cord at greater efficiency and volume than oligodendrocytes in the brain. Understanding how and where a building block of myelin is produced could assist researchers in looking for ways to thwart myelin destruction or to promote myelin repair in certain areas.
The cell protein known as mTOR (short for mechanistic target of rapamycin) is necessary for the production of cholesterol in oligodendrocytes. By recognizing this protein, researchers may be able to target it to enhance cholesterol and myelin production.
The cell protein mTOR is also critical for maintaining the already-formed myelin structures in the central nervous system.

Source-Eurekalert